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Abstract
The cyclic h-sheet antimicrobial peptide tachyplesin I (T-SS) was found to show 280-fold higher affinity for lipopolysaccharides (LPS)
compared with acidic phospholipids, whereas the linear a-helical peptide F5W-magainin 2 (MG2) could not discriminate between LPS and
acidic phospholipids. The recognition site was the lipid A moiety and the cyclic structure was crucial to this specific binding. The cyclic
structure also endowed the peptide with very rapid outer membrane (OM) permeabilization. D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Cationic antimicrobial peptides are widely recognized as
important components in innate immunity of animals and
insects [1–3]. These peptides have different secondary
structures, such as single a-helices, helix–turn–helix hair-
pin motifs, h-sheets stabilized by disulfide bonds, loops,
and extended structures. They also show a wide variety of
mechanisms of action; some peptides kill bacteria by per-
meabilizing membranes, whereas others enter cells, inhibit-
ing macromolecule synthesis. The reasons for such diversity
of antimicrobial peptides and their relationships between
their structures and functions are not well understood.
Tachyplesin I (T-SS) from horseshoe crab hemolymph
and magainin 2 from frog skin (Fig. 1) are representative
membrane-acting antimicrobial peptides with cyclic h-sheet
and linear a-helical structures (in membranes), respectively
[4,5]. The modes of action of these peptides are rather
similar despite their different three-dimensional structures;
both peptides form transient pores in acidic phospholipid
membranes and translocate across the membranes upon pore
disintegration [6]. However, we speculate that the cyclic h-
sheet structure of T-SS should endow the peptide with some
characteristics that the helical magainin peptide does not
possess. In this study, we found that T-SS showed high
affinity for lipopolysaccharides (LPS) compared with acidic
phospholipids, whereas the magainin peptide could not
discriminate between the two negatively charged lipids.
Furthermore, a linear tachyplesin analog (T-Acm, Fig. 1)
behaved similarly to the magainin peptide, suggesting the
importance of the cyclic structure in the unique character-
istics of T-SS.
2. Materials and methods
2.1. Materials
T-SS, T-Acm, and F5W-magainin 2 (MG2) were synthe-
sized by fluoren-9-ylmethoxycarbonyl (Fmoc)-based solid
phase synthesis and authenticated as described elsewhere
(Fig. 1) [7,8]. LPS (smooth type and Re595) from Salmo-
nella minnesota, diphosphoryl lipid A from S. minnesota
Re595, egg yolk L-a-phosphatidylcholine (EYPC), L-a-phos-
phatidyl-DL-glycerol enzymatically converted from EYPC
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(EYPG), carbonyl cyanide m-chlorophenylhydrazone
(CCCP), and polymixin B sulfate were obtained from Sigma
(St. Louis, MO). N-phenyl-1-naphthylamine (NPN) was
purchased from Kanto Chemical (Tokyo, Japan). Spectrog-
rade organic solvents were supplied by Dojindo (Kuma-
moto, Japan). All other chemicals were from Wako and were
of special grade. The buffers were prepared with double-
distilled water.
2.2. Binding
The binding of the peptides to various membranes was
determined by direct ultracentrifugation assay. LPS and
phospholipids were dissolved in 1,1,1,3,3,3-hexafluoro-2-
propanol and chloroform, respectively. The concentrations
of the stock solutions were determined by phosphorous
analysis [9]. Negatively charged LPS, lipid A or EYPG
was mixed with zwitterionic EYPC at a ratio of 1:9
(phosphorous basis) in ground glass tubes, and the solvent
was removed in a rotary evaporator. After further drying
under vacuum overnight, the lipid film was hydrated with 1
ml of a 20 AM peptide solution in 10 mM HEPES/150 mM
NaCl/1 mM EDTA (pH 7.4) buffer and vigorously vortex-
mixed to produce multilamellar vesicles (MLVs). The sus-
pension was equilibrated at 30 jC overnight. The lipid
vesicles were sedimented by ultracentrifugation at
155,000 g for 1 h. The concentration of the free peptide
in the supernatant was determined on the basis of Trp
fluorescence in the presence of 20 mM SDS. Contamination
by unsedimented lipids in the supernatant was checked by
phosphorous analysis. Correction for free peptide concen-
tration was carried out when necessary.
2.3. Outer membrane (OM) permeabilization
The OM permeabilization activity of peptides was inves-
tigated by NPN uptake assay [10]. Briefly, 1 ml of an over-
night culture of Escherichia coli (ATCC25922) was added to
50 ml of fresh 3% (w/v) trypticase soy broth (TSB) medium
and grown to an optical density at 600 nm of 0.4–0.6. The
cells were washed with buffer (5 mM HEPES-NaOH/5 mM
glucose/100mMNaCl/5 AMCCCP, pH 7.4) and resuspended
in the same buffer. For fluorescence measurements, 2-ml
aliquots of cell suspension (optical density at 600 nm= 0.5)
were prepared in cuvettes and 20 Al of 1 mM NPN solution
in acetone was added followed by 20 Al of peptide aqueous
solution. The fluorescence of NPN was monitored on a Shi-
madzu RF-5000 spectrofluorometer at an excitation wave-
length of 350 nm and an emission wavelength of 420 nm at
30 jC. The maximal value of NPN uptake was determined
after addition of polymixin B sulfate (0.64 mg/ml, 10 Al).
2.4. CD spectra
Small unilamellar vesicles (SUVs) for CD experiments
were prepared by sonication of MLVs under a nitrogen
atmosphere for 15 min (5 min 3 times) using a probe-type
sonicator. Tris buffer (10 mM Tris/150 mM NaCl/1 mM
EDTA, pH 7.4) was used to avoid absorption of UV light at
shorter wavelengths. Metal debris from the titanium tip of
the probe was removed by centrifugation. CD spectra were
measured on a Jasco J-720 apparatus interfaced to an NEC
PC9801 microcomputer, using a 1-mm path-length quartz
cell to minimize the absorbance due to buffer components.
The instrumental outputs were calibrated with nonhygro-
scopic ammonium d-camphor-10-sulfonate [11]. Eight scans
were averaged for each sample. The averaged blank spectra
(vesicle suspension or buffer) were subtracted.
3. Results
3.1. Binding
Fig. 2 shows binding isotherms of the three cationic
peptides for 10% phosphorous, LPS-, diphosphoryl lipid
Fig. 1. Amino acid sequences of the peptides used in this study.
Fig. 2. Binding isotherms at 30 jC. The binding isotherms of the peptides to
EYPC membranes containing 10 mol% (phosphorous basis) acidic lipids in
10 mM HEPES/150 mM NaCl/1 mM EDTA (pH 7.4) buffer were directly
determined by ultracentrifugation assay. The amount of peptide bound to
lipid phosphorous (mol/mol) is plotted as a function of free peptide con-
centration. Peptide/acidic lipid: ., T-SS/LPS (Re595); w , T-SS/diphos-
phoryl lipid A; o, T-SS/EYPG; E, T-Acm/ LPS (Re595); n, MG2/LPS
(Re595); 5, MG2/EYPG.
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A- or EYPG-containing EYPC membranes at 30 jC. These
peptides are known to hardly bind to zwitterionic EYPC
[12–14]. MG2 exhibited similar weak binding to LPS- and
EYPG-loaded membranes (open versus closed squares). The
initial slopes of the isotherms were about 16 M  1. At
higher free peptide concentrations, cooperative binding was
observed, as reported previously [8]. The binding behavior
of T-SS against EYPG-incorporated bilayers was similar to
that of MG2, although cooperative binding started at a lower
free peptide concentration (open circles). The slope of the
double-logarithmic plot (not shown) was 3.3. In contrast, T-
SS bound to LPS- and diphosphoryl lipid A-doped bilayers
very strongly (closed circles and open diamonds). The initial
slopes of the isotherms were approximately 4400 M  1. On
the other hand, the affinity of the linear analog T-Acm for
LPS-containing membranes was as weak as that for MG2
(closed triangles). T-Acm also showed similar weak binding
to EYPG-containing bilayers (data not shown).
3.2. OM permeabilization
To evaluate the membrane permeabilizing activities of
these peptides, the dye leakage assay was performed using
LPS-containing liposomes [15]. However, the interpretation
of the results was complicated, because T-SS induced
significant aggregation of vesicles (data not shown). There-
fore, we examined peptide-induced perturbation of OM
using the NPN assay [10], which is more biologically
relevant than the liposome study. The hydrophobic dye
NPN is normally excluded from OM but is partitioned into
perturbed OM exhibiting increased fluorescence. In most
cases, the time course of fluorescence increase was de-
scribed by single exponential kinetics with a limiting value
(data not shown). Therefore, the maximal limiting fluores-
cence (Fig. 3A) and the time (t1/2) at which half maximal
fluorescence was observed (Fig. 3B) could describe NPN
uptake kinetics satisfactorily. The maximal OM perturbation
was dose-dependent and in the order T-SS >MG2cT-Acm
except for very low peptide concentrations, although differ-
ences were not large (Fig. 3A). The rate of OM perturbation
was in the order T-SScT-Acm>MG-2 (Fig. 3B). Interest-
ingly, the rate of T-SS-induced NPN uptake was dose-
independent.
3.3. CD spectra
Secondary structures of the tachyplesin peptides were
estimated by CD spectrometry (Fig. 4). T-SS in aqueous
solution adopts a conformation consisting of an antiparallel
h-sheet and a type II h-turn with flexible N- and C-termini
[16]. The CD spectrum of T-SS in buffer (broken trace in
Fig. 4A) exhibited two positive bands (230 and 198 nm) and
one negative band (207 nm), as reported previously [17,18].
The peak at 198 nm is characteristic of antiparallel h-sheet
structures, whereas the other two bands are assignable to
turn structures [19]. The presence of EYPG/EYPC bilayers
markedly changed the CD spectrum (dotted trace in Fig.
4A). The positive band at 230 nm was shifted by 3 nm and
enhanced in intensity. A strong negative band and a shoul-
der were observed at 203 and 214 nm, reminiscent of turn
and antiparallel h-sheet structures, respectively [19]. The
sheet and turn structures as well as the flexible termini might
be more stabilized in membranes, resulting in strong CD
signals. Our infrared study indicated that T-SS mainly forms
an antiparallel h-sheet that lies on the surface of an acidic
phospholipid-containing membrane [13]. In the presence of
LPS-containing vesicles (solid trace in Fig. 4A), the CD
spectrum was further intensified.
In contrast to T-SS, T-Acm lacking S–S bridges assumed
a random structure in solution (broken trace in Fig. 4B),
similarly to a linear T-SS analog with the four Cys residues
replaced by Ala [18]. The spectrum in the coexistence of
LPS-containing vesicles showed a shallow minimum at 217
nm (solid trace in Fig. 4B), indicating an induction of a h-
sheet structure [19]. All spectra in the presence of vesicles
Fig. 3. Peptide-induced OM permeabilization. Permeabilization of E. coli
OM was estimated by NPN assay [10]. The NPN uptake kinetics are ex-
pressed by (A) maximal NPN fluorescence and (B) the time (t1/2) at which
half maximal fluorescence was observed. Peptide: ., T-SS;E, T-Acm; n,
MG2.
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were those of membrane-bound forms, because further
addition of lipids did not markedly alter the spectra.
4. Discussion
Elucidation of interactions between antimicrobial pepti-
des and LPS are important not only for understanding the
mechanism of killing of gram-negative bacteria but also for
development of anti-endotoxin agents. T-SS and magainins
are known to bind to LPS [4,15,20] similarly to other
antimicrobial peptides [10,21]. These peptides also show
affinity for acidic phospholipids [8,12,13]. Magainin–acidic
phospholipid interactions have been extensively investi-
gated [22] and the acidic phospholipid selectivity of the
peptide can be explained by simple electrostatic interactions
[23]. However, it is not clear whether interactions between
the peptides and LPS are specific or merely electrostatic
interactions as in the case of magainin–acidic phospholipid.
EYPC bilayers doped with LPS or EYPG are a suitable
system in which to address this question. We used LPS from
S. minnesota because their chemical structures have been
extensively studied [24–27] and they are readily available
commercially. We also tried to determine binding isotherms
using smooth-type LPS. However, experimental problems
such as incomplete free/bound separation hampered precise
determination.
Fig. 2 clearly shows that T-SS discriminates between
LPS and EYPG and that the lipid A moiety of the LPS
constitutes the binding site, although the secondary struc-
tures were similar upon binding to both types of lipid (Fig.
4A). The 280-fold difference in partition coefficient be-
tween LPS and EYPG corresponds to a Gibbs free energy
difference of 14 kJ/mol. The cyclic structure of T-SS was
crucial for this specific binding because T-Acm did not
show high affinity for LPS. The LPS-bound conformation
of T-Acm was also rather different from that of T-SS (Fig.
4). Polymyxin B, a strong LPS binder, also has a cyclic
structure and recognizes lipid A [28]. The LPS binding
activity of cyclic bactenecin was reported to be significantly
reduced upon linearization [29]. In contrast to T-SS, the
affinity of MG2 for LPS was comparable to that for EYPG.
That is, magainin’s preference of LPS over EYPC is a result
of simple electrostatic interactions. T-SS and MG2 exhibited
cooperative binding to EYPG-containing bilayers, in keep-
ing with oligomeric pore formation in this type of mem-
brane [8,30,31].
The first step to antimicrobial action against gram-neg-
ative bacteria is OM permeabilization, which was estimated
by the NPN assay. The minimum inhibitory concentration
against E. coli is in the order T-SS (0.5 AM) <T-Acm (2
AM)<MG2 (20 AM) [32]. In contrast, the extent of NPN
uptake for T-SS was the largest, yet not markedly different
from those of the other peptides (Fig. 3A). T-SS also more
strongly permeabilizes negatively charged phospholipid
membranes mimicking inner membranes than T-Acm [13]
and MG2 [32], suggesting that permeabilization of both
outer and inner membranes contributes to overall antimicro-
bial activity. It should be noted that in the OM permeabi-
lization experiments, peptide binding was much more
complete than in the binding experiments (Fig. 2) using
EYPC-based membranes containing only 10% LPS. The
NPN assay also revealed unique properties of T-SS: the
uptake rate of T-SS was very rapid (several seconds) and
dose-independent (Fig. 3B). The latter observation sug-
gested that the mode of OM permeabilization by T-SS is
an ‘‘all-or-none’’ process. That is, some bacterial cells
undergo rapid and complete OM permeabilization, whereas
the rest remain intact.
In conclusion, the cyclic h-sheet structure of T-SS
endows the peptide with LPS recognition ability and fast
OM permeabilization activity. Thus, this study provides an
example of a relationship between structural diversity and
functional variety of antimicrobial peptides.
Fig. 4. Secondary structure. CD spectra of 20 AM T-SS (A) and T-Acm (B)
were obtained in 10 mM Tris/150 mM NaCl/1 mM EDTA (pH 7.4) buffer
(broken trace) and in the presence of 1 mM LPS (Re595)/EYPG (1/9, solid
trace) and EYPG/EYPC (1/9, dotted trace) SUVs at 30 jC.
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